Derek Jantz | Co-Founder And Chief Scientific Officer
Precision Biosciences

Derek Jantz, Co-Founder And Chief Scientific Officer, Precision Biosciences

Derek is a 15-year veteran of the genome editing industry. As a protein engineer, he was an early developer of zinc finger technology and has spent most of his research career designing proteins for genome editing applications. He has a B.A. in biology from the University of Colorado at Boulder and a PhD in Biophysics from Johns Hopkins University School of Medicine. Derek’s passions include writing holiday themed poetry and finding ways to slip sci-fi references into corporate presentations. Dr. Jantz co-founded Precision BioSciences in 2006 after co-inventing a novel method for modifying the DNA-recognition properties of homing endonucleases. Since that time, he has served as VP of Scientific Development and Chief Scientific Officer.


Conference Day 1: Thursday 16th May 2019 @ 14:15

Translating in vivo genome editing capabilities into therapeutics

Conference Day 1: Thursday 16th May 2019 @ 14:35

Panel discussion: Delivering on the Promise of Gene Therapy - Making genetic therapies a reality for patients

Attendees will have the opportunity to hear from a panel of experts as they discuss the importance of commercial, scientific and clinical working together, every step of the way, from development to commercialization, to bring a new treatment to patients.

Conference Day 2: Friday 17th May 2019 @ 09:00

Keynote panel discussion: Exploring advances in gene editing technology, therapeutics and research

  • Best strategies for implementing new methods across the field of clinical research, now and for the future
  • Optimisation of the delivery of gene editing technology
  • How to minimise off-target effects and mutations for the safe and effective delivery of gene editing technology
  • Discussion of ethical and regulatory challenges, current legislation, how to navigate ethical concerns in light of the growing scale of genome editing. Most recently the CRISPR babies that were born in 2018
last published: 14/May/19 13:35 GMT

back to speakers

The World Advanced Therapies and Regenerative Medicine Congress and Exhibition is an international conference and exhibition featuring the latest in advanced therapies, bioengineering and surrounding technology. To attend the conference which features global leaders in the biopharma and regenerative medicine industries, there is a registration fee. The exhibition is free to visit.

Register your pass here.